Matson, Inc. (NYSE: MATX) announced today that Joel Wine, Senior Vice President and Chief Financial Officer, will present an overview of the Company and respond to questions at the Stephens...

Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced a...

In today's corporate development environment, people factors—from integrating corporate cultures to maintaining engagement and retaining key talent after a deal—have emerged as the definitive...

Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative therapies in cardio-renal disease, will deliver two key presentations...

Ten teams from universities around the world participated in the first design competition sponsored by the North Atlantic Treaty Organization Allied Command Transformation at the annual...

VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the third round of 21 highly...

Visionary automotive company Neuron EV has unveiled two new exciting products: T/ONE and TORQ at the Second Annual Import Expo in Shanghai, China. Neuron EV is unique from the group of well-known...

Cisco Partner Summit -- Today, at Cisco Partner Summit, Cisco announced a renewed commitment to Small Business by offering customers and partners a simple, secure and flexible portfolio, dedicated...

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, President and Chief Executive Officer, and Brian Poff, Executive Vice President and...

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release version of CarnoSyn® beta-alanine, is showcasing several new...

Barchart, a leading provider of commodity data and agribusiness solutions, has announced the dates and topics for cmdtyExchange 2020 (www.cmdtyexchange.com), its annual event which highlights the...

Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an investigational, oral SYK/JAK inhibitor, will...

New clinical data from Sanofi's oncology and rare blood disorders portfolios and pipelines will be featured, including four oral presentations and 18 posters, at the 61st American Society of...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that interim results from a Phase 1 trial studying Actimab-A in combination with CLAG-M have been accepted for...

Viracta Therapeutics, Inc. (the "Company"), a precision oncology company targeting virus-associated malignancies, announced today that its lead investigator, Dr. Pierluigi Porcu of the Sidney...

Epson LabelWorks PX, the US-based sales office for Seiko Epson Corporation, announced today that it will demonstrate its new industrial printer solutions designed specifically to address the need...

CTI BioPharma Corp. (Nasdaq: CTIC) today announced four poster presentations and one oral presentation supporting the Company's pacritinib development program at the 61st American Society of...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that abstracts for both fimepinostat and...

Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced today...

Topia, the leading provider of Global Mobility Management (GMM) software, today announced the results of a "feet on the street" survey conducted at two recent high-profile HR events. Topia polled...

Mattel (NASDAQ: MAT) announced today the winner of the 2019 Hot Wheels Legends Tour. The Nash custom car, built by best friends Greg Salzillo and Dave Ford, will be joining the Hot Wheels...

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will share new and updated data for two investigational medicines for blood cancers and a third for a rare blood disease at...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that new findings from its pivotal Phase 3 SIERRA trial for Iomab-B (Iodine-131 apamistamab) that support its...

AllianceRx Walgreens Prime and Duquesne University School of Pharmacy recently announced results from research analyzing data from cystic fibrosis (CF) patients prescribed cystic fibrosis...